Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats

Acta Physiologica

Volumn 205, Issue 1, 2012, Pages 124-132

  Zicha, J ^a   Dobesova Z ^a   Kunes J ^a   Vaneckova I ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Adulthood; Endogenous nitric oxide dependent vasodilation; Endothelin 1; ET A receptor antagonist; Pre puberty; Sympathetic vasoconstriction

Indexed keywords

AMBRISENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; NITRIC OXIDE;

ADRENERGIC SYSTEM; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; FEMALE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; VASODILATATION;

AGE FACTORS; ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; FEMALE; HYPERTENSION; PHENYLPROPIONATES; PYRIDAZINES; RATS; RATS, INBRED DAHL; RECEPTOR, ENDOTHELIN A; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84859146045     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2012.02395.x     Document Type: Article

References (34)

1. A receptor antagonism. Circulation 103, 319-324.
2. Barton, M. & Yanagisawa, M. 2008. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86, 485-498.
3. A receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension 31, 499-504.
4. Barton, M., Vos, I., Shaw, S., Boer, P., d'Uscio, L.V., Gröne, H.J., Rabelink, T.J., Lattmann, T., Moreau, P. & Lüscher, T.F. 2000. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 11, 835-845.
5. A receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42, 811-817.
6. Dahl, L.K., Knudsen, K.D., Heine, M.A. & Leitl, G.J. 1968. Effects of chronic excess salt ingestion. Modification of experimental hypertension in the rat by variations in the diet. Circ Res 22, 11-18.
7. 2 hybrid studies. J Hypertens 20, 945-955.
8. Doucet, J., Gonzalez, W. & Michel, J.B. 1996. Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency. J Cardiovasc Pharmacol 27, 643-651.
9. Fink, G.D., Johnson, R.J. & Galligan, J.J. 2000. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension 35, 464-469.
10. Hojná, S., Kadlecová, M., Dobešová, Z., Valoušková, V., Zicha, J. & Kuneš, J. 2007. The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol Cell Biochem 297, 21-29.
11. Ikeda, T., Ohta, H., Okada, M., Kawai, N., Nakao, R., Siegl, P.K., Kobayashi, T., Maeda, S., Miyauchi, T. & Nishikibe, M. 1999. Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension. Hypertension 34, 514-519.
12. Kassab, S., Miller, M.T., Novak, J., Reckelhoff, J., Clower, B. & Granger, J.P. 1998. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 31, 397-402.
13. Kohan, D.E. 2010. Endothelin, hypertension and chronic kidney disease: new insights. Curr Opin Nephrol Hypertens 19, 134-139.
14. Kuneš, J., Dobešová, Z. & Zicha, J. 2002. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci (Lond) 102, 269-277.
15. Minami, N., Imai, Y., Hashimoto, J. & Abe, K. 1995. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci (Lond) 89, 177-182.
16. A receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt. Eur J Pharmacol 259, 339-342.
17. A receptor antagonist, J-105859. J Hypertens 18, 1815-1823.
18. Opočenský, M., Kramer, H.J., Bäcker, A., Vernerová, Z., Eis, V., Červenka, L., Čertíková Chábová, V., Tesař, V. & Vaněčková, I. 2006. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension. Hypertension 48, 965-971.
19. A receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Hypertension 37, 1444-1449.
20. Paulis, L., Líšková, S., Pintérová, M., Dobešová, Z., Kuneš, J. & Zicha, J. 2007. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol (Oxf) 191, 255-266.
21. Rossi, N.F., Black, S.M., Telemaque-Potts, S. & Chen, H. 2004. Neuronal nitric oxide synthase activity in the paraventricular nucleus buffers central endothelin-1-induced pressor response and vasopressin secretion. J Cardiovasc Pharmacol 44(Suppl 1), S283-S288.
22. Rothermund, L., Vetter, R., Dieterich, M., Kossmehl, P., Gogebakan, O., Yagil, C., Yagil, Y. & Kreutz, R. 2002. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension. Circulation 106, 2305-2308.
23. A receptor antagonist darusentan in salt-sensitive genetic hypertension. Eur J Pharmacol 468, 209-216.
24. Schiffrin, E.L. 2001. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14(6 Pt 2), 83S-89S.
25. Schnackenberg, C.G., Welch, W.J. & Wilcox, C.S. 1998. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32, 59-64.
26. d'Uscio, L.V., Barton, M., Shaw, S., Moreau, P. & Lüscher, T.F. 1997. Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade. Hypertension 30, 905-911.
27. Vaněčková, I., Kramer, H.J., Bäcker, A., Schejbalová, S., Vernerová, Z., Eis, V., Opočenský, M., Dvořák, P. & Červenka, L. 2006. Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats. Vascul Pharmacol 45, 163-170.
28. + transport in red blood cells of Dahl rats. Effects of age and salt. Hypertension 15, 612-627.
29. Zicha, J. & Kuneš, J. 1999. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 79, 1227-1282.
30. Zicha, J., Kuneš, J. & Jelínek, J. 1986. Experimental hypertension in young and adult animals. Hypertension 8, 1096-1104.
31. Zicha, J., Byšková, E., Kuneš, J., Pohlová, I. & Jelínek, J. 1987. Sodium pump activity in young and adult salt hypertensive Dahl rats. Klin Wochenschr 65(Suppl 8), 76-81.
32. Zicha, J., Kuneš, J., Lébl, M., Pohlová, I., Slaninová, J. & Jelínek, J. 1989. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension. Am J Physiol 256, R138-R145.
33. Zicha, J., Dobešová, Z. & Kuneš, J. 2001. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 19, 247-254.
34. Zicha, J., Dobešová, Z. & Kuneš, J. 2006. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in l-NAME hypertensive rats. Hypertens Res 29, 1021-1027.